ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
E2: what is "high" and "low"
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 201426" data-attributes="member: 13851"><p>[URL unfurl="true"]https://www.excelmale.com/forum/threads/at-what-point-does-estrogen-get-high-enough-to-start-encouraging-gyno-production.23422/#post-201083[/URL]</p><p></p><p></p><p></p><p></p><p><strong>Gynecomastia Evaluation and Treatment: EAA clinical practice guidelines (2019)</strong></p><p><strong></strong></p><p><strong></strong></p><p><strong>INTRODUCTION—DEFINITION</strong></p><p><strong></strong></p><p><strong>Gynecomastia (GM) is a benign proliferation of glandular tissue of the breast in men.</strong> The term is derived from the Greek words ‘gyneka’ (woman) and ‘mastos’ (breast). <strong>GM can be unilateral or bilateral, most commonly the latter (Nuttall, 1979; Mieritz et al., 2017).</strong> <strong><u>GM has to be distinguished from pseudogynecomastia (i.e., lipomastia), which is characterized by excess fat deposition without glandular proliferation</u>. GM is a common condition with a prevalence that varies widely between 32 and 65%, depending on the age of the subjects studied and the criteria used for GM definition (Braunstein, 2007). GM shows three discrete peaks throughout a man’s lifespan: the first peak is observed during infancy, the second during puberty, and the third in middle-aged and elderly men (Nachtigall, 1965; Knorr & Bidlingmaier, 1975; Nuttall, 1979).</strong> <strong><u>The purpose of the assessment of GM should be the detection of underlying pathological conditions and the discrimination from other breast lumps that mimic GM, particularly breast cancer</u>.</strong></p><p></p><p></p><p></p><p></p><p>[ATTACH=full]14319[/ATTACH]</p></blockquote><p></p>
[QUOTE="madman, post: 201426, member: 13851"] [URL unfurl="true"]https://www.excelmale.com/forum/threads/at-what-point-does-estrogen-get-high-enough-to-start-encouraging-gyno-production.23422/#post-201083[/URL] [B]Gynecomastia Evaluation and Treatment: EAA clinical practice guidelines (2019) INTRODUCTION—DEFINITION Gynecomastia (GM) is a benign proliferation of glandular tissue of the breast in men.[/B] The term is derived from the Greek words ‘gyneka’ (woman) and ‘mastos’ (breast). [B]GM can be unilateral or bilateral, most commonly the latter (Nuttall, 1979; Mieritz et al., 2017).[/B] [B][U]GM has to be distinguished from pseudogynecomastia (i.e., lipomastia), which is characterized by excess fat deposition without glandular proliferation[/U]. GM is a common condition with a prevalence that varies widely between 32 and 65%, depending on the age of the subjects studied and the criteria used for GM definition (Braunstein, 2007). GM shows three discrete peaks throughout a man’s lifespan: the first peak is observed during infancy, the second during puberty, and the third in middle-aged and elderly men (Nachtigall, 1965; Knorr & Bidlingmaier, 1975; Nuttall, 1979).[/B] [B][U]The purpose of the assessment of GM should be the detection of underlying pathological conditions and the discrimination from other breast lumps that mimic GM, particularly breast cancer[/U].[/B] [ATTACH type="full"]14319[/ATTACH] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
E2: what is "high" and "low"
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top